Executive Order Targets Prescription Drugs & Health Insurance to Promote Competition

Read the complete Executive Order online.

The ACR supports efforts to reduce the cost of high-priced treatments for patients with rheumatic diseases, as long as the ability of rheumatologists and healthcare teams to provide safe and effective treatment is not restricted.² The ACR will also be monitoring implementation efforts and be prepared to advocate against the Most Favored Nation (MFN) model if the Centers for Medicare & Medicaid Services introduces it again in response to this Executive Order.

Reference

1. Fact Sheet: Executive order on promoting competition in the American economy. WhiteHouse.gov. 2021 Jul 9.
2. American College of Rheumatology. 2021 ACR top priorities. 2021.